Category: Wall Street BeatSyndicate content

Baxter says HQ will stay in Illinois, stays coy on Boston plans

August 29, 2014 by Brad Perriello

Baxter International says it will keep its headquarters in Illinois, despite recent reports of a possible move to Boston, but stays coy on its actual plans in The Hub.

Baxter says HQ will stay in Illinois, stays coy on Boston plans

Covidien acquires Reverse Medical | Medtech Wall Street news for the week of August 25, 2014

August 28, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Covidien snaps up Reverse Medical; Standard & Poor's maintains credit watch on Medtronic over Covidien buy; Allergan can't delay shareholder vote on hostile Valeant bid; Medtronic drops $200M on Dutch DBS firm Sapiens; Nobel Biocare's Q2 profits double as it fields buyout interest

Covidien snaps up Reverse Medical

August 22, 2014 by Brad Perriello

YYmeta

Medtronic drops $200M on Dutch DBS firm Sapiens

August 26, 2014 by Brad Perriello

Medtronic pays $200 million in cash for Sapiens Steering Brain Stimulation, a Dutch firm that makes deep-brain stimulation devices for treating neurological conditions.

Medtronic drops $200M on Dutch DBS firm Sapiens

Valeant sues Allergan for special meeting after show of shareholder support

August 25, 2014 by Arezu Sarvestani

Valeant Pharmaceuticals files a lawsuit aiming to force Allergan to hold a special shareholder meeting after hand-delivering 1,500 pages of documents showing shareholder support.

Valeant files new lawsuit in Allergan acquisition saga

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Allergan can't delay shareholder vote on hostile Valeant bid

August 22, 2014 by Brad Perriello

Valeant Pharmaceuticals and Pershing Square Capital Management reportedly plan to ask Allergan for a shareholder vote on their hostile takeover attempt, after a federal judge rules that Allergan's insider trading lawsuit won't delay the meeting.

Allergan can't delay shareholder vote on hostile Valeant bid

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Standard & Poor's maintains credit watch on Medtronic over Covidien buy

August 22, 2014 by Brad Perriello

Standard & Poor's Ratings Services maintains a credit watch on Medtronic over its $43 billion buyout of Covidien, pending Medtronic's ability to control its indebtedness.

Standard & Poor's puts credit watch on Medtronic over Covidien buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien snaps up Reverse Medical

August 22, 2014 by Brad Perriello

Covidien snaps up Reverse Medical and its line of vascular devices for an unspecified amount.

YYmeta

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp